<DOC>
	<DOCNO>NCT00782327</DOCNO>
	<brief_summary>To study effect losartan ( angiotensin receptor blocker-ARB ) aortic root growth patient Marfan syndrome , already treat beta-blockers ( BB ) . The effect losartan compare placebo . Losartan placebo add treatment regimen two-step up-titration scheme 2 week . Start dose Losartan 25 mg subject 50kg weight 50mg weight 50kg . Uptitration guide tolerance drug patient . Patients contact phone call assessment side-effects second step uptitration . Daily maximal dos Losartan 50mg subject 50kg weight 100mg weight 50kg</brief_summary>
	<brief_title>Randomized , Double-blind Study Evaluation Effect Losartan Versus Placebo Aortic Root Dilatation Patients With Marfan Syndrome Under Treatment With Beta-blockers</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Marfan Syndrome</mesh_term>
	<mesh_term>Arachnodactyly</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Patients &gt; 10 year Diagnosis MFS , accord Ghent criterion and/or genetically prove FBN1 mutation linkage Consent obtain ( write ) either patient his/her parent ( &lt; 18y Zscore aorta level sinus Valsalva ≥2 ( BSA adjust ) ARB naïve patient Poor echocardiographic window , limit accurate measurement aortic root Contraindication ARB : Bilateral renal artery stenosis , renal function abnormality ( creatinine normal age ) , hyperkalemia Intolerance ARB ( eg angioedema ) Pregnancy breast feed woman Absence effective contraception Liver function abnormality Heart Failure Patients include clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>